Shares of Tactile Systems Technology Inc (NASDAQ:TCMD) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $14.85 and last traded at $14.53, with a volume of 62,606 shares changing hands. The stock had previously closed at $13.71.

Several analysts have issued reports on TCMD shares. BTIG Research started coverage on shares of Tactile Systems Technology in a research report on Monday, August 22nd. They issued a “buy” rating and a $18.00 price objective for the company. Canaccord Genuity started coverage on shares of Tactile Systems Technology in a research report on Thursday, August 25th. They issued a “buy” rating and a $21.00 price objective for the company. William Blair started coverage on shares of Tactile Systems Technology in a research report on Monday, August 22nd. They issued an “outperform” rating for the company. Finally, Piper Jaffray Cos. started coverage on shares of Tactile Systems Technology in a research report on Monday, August 22nd. They issued an “overweight” rating and a $17.00 price objective for the company.

The company’s market capitalization is $49.60 million. The firm has a 50 day moving average price of $13.39 and a 200-day moving average price of $13.39.

In other Tactile Systems Technology news, Director Peter H. Soderberg bought 100,000 shares of the stock in a transaction on Tuesday, August 2nd. The shares were bought at an average price of $10.00 per share, with a total value of $1,000,000.00. Following the purchase, the director now directly owns 5,000 shares in the company, valued at approximately $50,000. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Tactile Systems Technology, Inc is a medical technology company. The Company develops and provides medical devices for the treatment of chronic diseases at home. The Company focuses on advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.